Tango Therapeutics, Inc. (TNGX) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts TNGX Hot Sheet
Join SI Premium – FREE
Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q3 EPS of ($0.14), $0.07 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $53.81 million versus the consensus estimate of $53.8 million.
For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades PulteGroup (PHM) to Outperform
- Raymond James Starts Shattuck Labs (STTK) at Strong Buy
- Seaport Global Securities Starts Funko (FNKO) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
